E2609 for Mild Cognitive Impairment Due to Alzheimer's Disease

Language Undefined Purpose: To evaluate the safety and efficacy of the experimental drug E2609 in people with mild cognitive impairment or mild dementia due to Alzheimer's disease.
Source: Alzheimers Clinical Trials - Category: Geriatrics Authors: Source Type: clinical trials